Integrated BioPharma, Inc. (OTCMKTS:INBP – Get Free Report)’s stock price dropped 2.2% on Wednesday . The stock traded as low as $0.20 and last traded at $0.22. Approximately 32,550 shares were traded during mid-day trading, an increase of 241% from the average daily volume of 9,557 shares. The stock had previously closed at $0.23.
Integrated BioPharma Stock Down 2.2 %
The business’s 50 day moving average is $0.20 and its 200-day moving average is $0.21.
Integrated BioPharma Company Profile
Integrated BioPharma, Inc, together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers.
Featured Articles
- Five stocks we like better than Integrated BioPharma
- Canadian Penny Stocks: Can They Make You Rich?
- How Much Can You Make in Stocks in One Month?
- Technology Stocks Explained: Here’s What to Know About Tech
- This Is the Top Large-Cap Stock Insiders Are Buying
- Top Biotech Stocks: Exploring Innovation Opportunities
- Capitalize on Micron’s 24% Drop—Wall Street Eyes Major Upside
Receive News & Ratings for Integrated BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integrated BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.
